FDA Warning Letters Released The Week Of Sept. 10
This article was originally published in The Gray Sheet
Executive Summary
bioMerieux Inc. receives letter citing quality system deficiencies following an inspection that lasted more than a month. Chart includes four additional device-related warning letters.